A 32-week gestation female infant born to a mother with poorly controlled gestational diabetes is admitted to the NICU at 4 hours of life with respiratory distress. Chest X-ray shows a fine reticular granular pattern with air bronchograms. Arterial blood gas shows pH 7.28, PaCO₂ 52 mmHg, PaO₂ 65 mmHg on 40% oxygen. The infant is intubated and given exogenous surfactant. Two hours post-surfactant, there is sudden onset of hypotension (mean BP 35 mmHg), bradycardia (HR 90), and reduced urine output. What is the most likely complication?

Question

Accepted Answer

B. Pulmonary Hemorrhage secondary to rapid improvement in lung compliance. ## Pulmonary Hemorrhage: A Complication of RDS Treatment

### Clinical Context

**Key Point:** Pulmonary hemorrhage is a rare but serious complication that can occur within hours after exogenous surfactant administration in preterm infants with RDS, particularly those at high risk (maternal diabetes, perinatal asphyxia, patent ductus arteriosus).

### Pathophysiology of Pulmonary Hemorrhage Post-Surfactant

1. **Rapid improvement in lung compliance:** Surfactant replacement dramatically reduces surface tension and improves alveolar ventilation and oxygenation.
2. **Sudden increase in pulmonary blood flow:** The rapid improvement in lung mechanics causes pulmonary vascular resistance to drop sharply, leading to increased left-to-right shunting (especially through a patent ductus arteriosus, common in preterm infants).
3. **Pulmonary capillary stress:** The sudden increase in pulmonary blood flow and capillary pressure overwhelms the fragile, immature capillary endothelium.
4. **Hemorrhage into alveoli:** Red blood cells leak into the alveolar space, causing pulmonary edema and hemorrhage. The infant may cough up or have endotracheal secretions that are blood-stained or frankly hemorrhagic.

### Clinical Presentation

| Feature | Details |
|---------|----------|
| **Timing** | 2–12 hours post-surfactant administration |
| **Respiratory signs** | Sudden worsening of oxygenation despite surfactant; pink or blood-tinged endotracheal secretions |
| **Hemodynamic signs** | Hypotension, tachycardia (or bradycardia if severe), poor perfusion |
| **Metabolic signs** | Metabolic acidosis, reduced urine output, signs of shock |
| **CXR findings** | Acute bilateral infiltrates (may appear as "whiteout") |

### Risk Factors for Pulmonary Hemorrhage Post-Surfactant

```mermaid
flowchart TD
  A[Preterm infant on surfactant]:::outcome --> B{Risk factors present?}:::decision
  B -->|PDA| C[Increased left-to-right shunt]:::action
  B -->|Maternal diabetes| D[Immature capillary endothelium]:::action
  B -->|Asphyxia| E[Capillary injury + RDS]:::action
  B -->|Sepsis| F[Inflammatory capillary leak]:::action
  C --> G[Pulmonary capillary pressure ↑]:::urgent
  D --> G
  E --> G
  F --> G
  G --> H[Pulmonary hemorrhage]:::urgent
```

**Clinical Pearl:** Maternal gestational diabetes (as in this case) is associated with delayed fetal lung maturation AND immature capillary endothelium, making these infants particularly vulnerable to pulmonary hemorrhage after surfactant.

### Management

1. **Immediate stabilization:** Maintain airway, increase ventilatory support (higher PEEP, increase FiO₂), correct hypotension with fluid bolus and inotropes (dopamine, dobutamine).
2. **Treat underlying PDA:** If present, consider indomethacin or ibuprofen (or surgical ligation if medical management fails).
3. **Supportive care:** Correct coagulopathy, maintain adequate hemoglobin, optimize ventilation to prevent further alveolar injury.
4. **Prognosis:** Mortality is significant (20–40%) if severe; survivors may have chronic lung disease.

**High-Yield:** Pulmonary hemorrhage is NOT an anaphylactic reaction to surfactant itself — it is a hemodynamic consequence of rapid improvement in lung mechanics in a vulnerable infant with immature pulmonary vasculature.

Answer

A. Spontaneous pneumothorax from barotrauma

Answer

C. Intraventricular hemorrhage from fluctuating cerebral perfusion

Answer

D. Surfactant-induced anaphylaxis

Explanation

Pulmonary Hemorrhage: A Complication of RDS Treatment

Clinical Context

Pathophysiology of Pulmonary Hemorrhage Post-Surfactant

Clinical Presentation

Risk Factors for Pulmonary Hemorrhage Post-Surfactant

Management

Practice similar questions

Join our NEET PG community

Feature	Details
Timing	2–12 hours post-surfactant administration
Respiratory signs	Sudden worsening of oxygenation despite surfactant; pink or blood-tinged endotracheal secretions
Hemodynamic signs	Hypotension, tachycardia (or bradycardia if severe), poor perfusion
Metabolic signs	Metabolic acidosis, reduced urine output, signs of shock
CXR findings	Acute bilateral infiltrates (may appear as "whiteout")